Network established to identify opportunities for regulation to support innovation within advanced therapies

The UK’s Cell and Gene Therapy Catapult, in partnership with the University of Birmingham, has launched a new network to engage with leading regulators, including the MHRA, to identify effective and efficient regulatory strategies that address the unique challenges of advanced therapies.

• Effective regulation of advanced therapies is vital to ensure patients can access transformative treatments promptly.
• With support from Innovate UK and the MHRA, the network will ensure timely access- preparing the sector for effective deployment and safeguarding patient safety.
• The network is one of seven new Centres of Excellence in Regulatory Science and Innovation established by Innovate UK. 

• These centres have been set up to develop tools, frameworks, and guidance to help shape the development and approval of medical innovations in the UK.